Josefin-Beate Holz,Karen Silence,Hans Ulrichts,Stefan De Buck,Jozef Bartunek,Robert Klamroth
申请号：
US14053875
公开号：
US20140044710A1
申请日:
2013.10.15
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The invention provides new uses for specific binders to the A1 domain of the von Willebrand Factor (vWF), in particular the use in patients with stable angina undergoing elective percutaneous coronary intervention. Furthermore, dosing schedules and use of suitable assays such as RIPA and RICO in the particular disease settings are provided.
